 ICMI 2009 Preliminary Scientific Schedule
Preliminary and subject to changeSunday, July 5, 2009
8:00 am-5:00 pm Pre-Congress Workshop (requires separate registration)
6:00 pm-7:00 pm Keynote Lecture: Studying the Microbiome in Mucosal Tissue
Chair: Richard Blumberg, MD, Brigham & Women’s Hospital
Brett Finlay, PhD, University of British Columbia 7:00 pm-9:00 pm President's Reception
Introductions by Thomas MacDonald, PhD, FRCPath, FMedSci, Barts and the London School of Medicine
and Dentistry & Scott Snapper, MD, PhD, Massachusetts General Hospital
Monday, July 6, 2009
8:30 am-9:00 am Tsuchiya Memorial Lecture
Programmed by SMI. Suppported by the Japanese Society for Mucosal Immunology
Chair: Toshifumi Hibi, MD, PhD, Keio University School of Medicine
Charles Elson, MD, Univeristy of Alabama at Birmingham
9:00 am-10:30 am Plenary Session: Molecular Basis of Microbial Immune Interactions at the Wet Surfaces of
the Body
Chair: Roy Curtiss, III, PhD, Arizona State University
• Intestine-microbe Mutualism in Health & Disease, Alex Chervonsky, MD, PhD, Univeristy of
Chicago
• Innate Immune Genetics, Asymptomatic Bacterial Carriage Versus Severe Disease,
Catharina Svanborg, PhD, Lund University
• How Does the Gut Differentiate between a Pathogen & a Commensal?, Jorge Galan, PhD, Yale
University School of Medicine
• Microbial Symbiosis and Intestinal Inflammation, Dennis Kasper, PhD, Brigham & Women's
Hospital
11:00 am-1:00 pm Plenary Session: Innate Immunity
Chair: Philip Smith, MD, University of Alabama at Birmingham
• Paneth Cells, Autophagy & Crohn’s Disease, Thad Stappenbeck, MD, PhD, Washington University
School of Medicine
• Epithelial PRR’s & Intestinal Homeostasis, Sergio Lira, MD, PhD, Mount Sinai School of Medicine
• Control of Innate Responses, Averil Ma, MD, PhD, University of California-San Francisco
• T-bet & Dendritic Cells, Graham Lord, MA, FRCP, PhD, King’s College London
• Innate Immunity & Airway Inflammation, Anuradha Ray, PhD, University of Pittsburgh School of
Medicine
1:00 pm-2:30 pm Lunch Break and Poster Session (authors present)
2:30 pm-3:45 pm Parallel Oral Abstract Sessions
• Regulatory T Cells 1
Programmed by SMI. Supported by Surface Barrier Immunology Study Group / Eisai
Chair: Scott Snapper, MD, PhD, Massachusetts General Hospital
• Epithelia
Chair: Wayne Lencer, MD, Children’s Hospital Boston
• Vaccines/Mucosal Infection
Chair: Michael Starnbach, PhD, Harvard Medical School
• Dendritic Cells 1
Chair: Hans Christian Reinecker, MD, Massachusetts General Hospital
• Innate Immunity 1
Chair: Akiko Iwasaki, PhD, Yale University School of Medicine 4:15 pm-5:30 pm Parallel Oral Abstract Sessions
• Lung
Chair: Benjamin Medoff, MD, Massachusetts General Hospital
• Inflammation
Chair: Lloyd Mayer, MD, Mount Sinai Medical Center
• Antibodies 1
Chair: Nadine Cerf-Bensussan, MD, PhD, INSERM
• Dendritic Cells 2
Chair: Ulf Yrlid, PhD, University of Gothenburg
• Antimicrobial Defenses
Chair: Jonathan Braun, MD, PhD, University of California Los Angeles 5:30 pm-6:00 pm Poster Session 6:00 pm-6:45 pm Distinguished Lecture
Transmissible Ulcerative Colitis & Colorectal Cancer Driven by T-bet in Dendritic Cells
Laurie Glimcher, MD, Harvard School of Public Health
Tuesday, July 7, 2009
8:30 am-10:30 am Plenary Session: State of the Art: Understanding of Mucosal Disease
Chair: Brian Kelsall, MD, National Institutes of Health
• HIV & the Gut, Danny Douek, MD, PhD, NIAID/NIH/DHHS
• IBD Genetics-linking to Immunology, Judy Cho, MD, Yale School of Medicine
• IBD Pathophysiology, Warren Strober, MD, NIH/NIAID
• Asthma, Dale Umetsu, PhD, Harvard Medical School
• Celiac Genetics, Dave Van Heel, BM, BCh, MA, DPhil, MRCP, Barts and the London School of
Medicine and Dentistry 11:00 am-1:00 pm Plenary Session: Immunoglobulin & B Cell Function at Mucosae
Chair: Charlotte Kaetzel, PhD, University of Kentucky
• Control of Class Switching to IgA, Andrea Cerutti, MD, Cornell University
• The Immunologic Functions of FcRn in Mucosal Tissues, Richard Blumberg, MD, Brigham
& Women's Hospital
• TACI and the Molecular Basis of IgA Deficiency and Common Variable Immunodeficiency, Raif
Geha, MD, Children's Hospital Boston
• The Poly Ig Receptor, Finn-Erik Johansen, PhD, University of Oslo
• Distinguished Service & Achievement Award Presentations
1:00 pm-2:00 pm SMI Member Business Meeting (open to all SMI members)
1:00 pm-2:30 pm Lunch Break and Poster Session (authors present)
2:30 pm-3:45 pm Parallel Oral Abstract Sessions
• Animal Models of IBD 1
Programmed by SMI. Supported by the Japanese Society for Mucosal Immunology
Chair: Takanori Kanai, MD, Tokyo Medical & Dental University
• Lymphocyte Homing
Chair: William Agace, PhD, Lund University
• Celiac Disease
Chair: Frits Koning, PhD, Leiden University Medical Center
• Cytokines/Chemokines at Mucosal Surfaces 1
Chair: J. Rodrigo Mora, MD, PhD, Massachusetts General Hospital
• Cell Interaction at Epithelium
Programmed by SMI. Supported by AMIS / Kyorin Pharmaceuticals
Chair: Mi-Na Kweon, MD, PhD, International Vaccine Institute 4:15 pm-5:30 pm Parallel Oral Abstract Sessions
• Animal Models of IBD 2
Chair: R. Balfor Sartor, MD, University of North Carolina
• Intestinal Inflammation in Humans
Chair: Stephan Targan, MD, Cedars Sinai Medical Center
• Innate Responses to Intestinal Infection
Chair: Ramnik Xavier, MD, Massachusetts General Hospital
• Cytokines/Chemokines at Mucosal Surfaces 2
Chair: Cox Terhorst, PhD, Beth Israel Hospital
• NALT/BALT and Oral Cavity
Programmed by SMI. Supported by AMIS / Kyorin Pharmaceuticals
Chair: Kohtaro Fujihashi, PhD, DDS, University of Alabama at Birmingham 5:30 pm-6:30 pm Poster Session
Wednesday, July 8, 2009
8:30 am-10:30 am Plenary Session: Brainstorming Session: Regulatory Cells which Control Mucosal Immunity &
Inflammation
Chair: Per Brandtzaeg, PhD, University of Oslo
• Regulatory T Cells & IL-10, Casey Weaver, MD, University of Alabama at Birmingham
• Regulatory T Cells which Control Ocular Inflammation, Rachel Caspi, PhD, National Eye
Institute
• A Second Chance: Mucosal Immune Regulation without the Need for Regulatory T Cells,
Hilda Cheroutre, PhD, La Jolla Institute for Allergy & Immunology
• Regulatory T Cells in Airway Inflammation, Juan Lafaille, PhD, New York University
• Regulatory T Cells at Mucosal Surfaces, Yasmine Belkaid, PhD, NIAID/NIH
11:00 am-1:00 pm Plenary Session: Progress in Mucosal Vaccines
Programmed by SMI. Supported by AMIS / Kyorin Pharmaceuticals
Chair: Ken Beagley, PhD, Queensland University of Technology
• Mucosal Adjuvants for Vaccines, Nils Lycke, MD, PhD, University of Goteberg
• IgG and Mucosal Immunity, John B. Robbins, MD, National Institutes of Health
• Rotaviral Vaccination, Harry Greenberg, MD, Stanford University
• Protection Against HIV in the Urogenital Tract, Robin J. Shattock, MD, University of London-
St. George’s
• Rice-based Vaccines: New Generation of Mucosal Vaccine, Hiroshi Kiyono, DDS, PhD,
University of Tokyo
1:00 pm-2:30 pm Lunch Break and Poster Session (authors present)
2:30 pm-3:45 pm Parallel Oral Abstract Sessions
• Regulatory T Cells 2
Chair: Howard Weiner, MD, Brigham & Women’s Hospital
• Urogenital
Chair: Chuck Wira, PhD, Dartmouth Medical School
• Mucosal Allergy
Chair: Cathryn Nagler, PhD, Massachusetts General Hospital
• Microbial Infections
Chair: James Fox, DVM, Massachusetts Institute of Technology
• Ocular Immunity & Tolerance
Chair: Joan Stein-Streilein, PhD, Harvard Medical School
4:15 pm-5:30 pm Parallel Oral Abstract Sessions
• Antibodies 2
Chair: Jenny Woof, PhD, University of Dundee Medical School
• HIV & Infections
Chair: Martin Zeitz, MD, Charite
• Probiotics
Programmed by SMI. Supported by Danone.
Chair: Richard Fedorak, MD, University of Alberta
• Innate Immunity 2
Chair: Eyal Raz, MD, University of California-San Diego
• TGFbeta & Other Immunosuppressive Molecules
Programmed by SMI. Supported by Surface Barrier Immunology Study Group / Eisai
Chair: Thomas MacDonald, PhD, FRCPath, FMedSci, Barts and the London School of Medicine and
Dentistry 5:30 pm-6:30 pm Poster Session
7:00 pm-9:00 pm Farewell Reception (requires additional registration)
Four days of immersion in the mucosal milieu with an evening soiree on Wednesday, July 8,
2009. The event begins under the stars at 7:00 pm in the Marriott atrium.
Thursday, July 9, 2009
8:30 am-10:30 am Plenary Session: Epithelium
Programmed by SMI. Supported by Eisai
Chair: Mamoru Watanabe, MD, PhD, Tokyo Medical & Dental University
• Stem Cell Niche in the Gut Epithelium & Beyond, D. Brent Polk, MD, Vanderbilt University
• Epithelial Regulation of Inflammation in the Gut, David Artis , PhD, University of Pennsylvania
• Developmental Regulation of Epithelial Defenses, Matthias Hornef , MD, Universitat Freiburg
• The XBP1-ER Stress Response & Defenses, Arthur Kaser, MD, Brigham & Women’s
Hospital
• Epithelial Cells Control Dendritic Cell Function via the Action of Multiple Mediators,
Maria Rescigno, PhD, European Institute of Oncology
11:00 am-1:00 pm Plenary Session: Brainstorming Session: Novel Cytokines at Mucosal Surfaces
Chair: Jo Viney, PhD, Amgen
• IL-12 & IL-23, Kevin Maloy, PhD, Dunn School of Pathology
• IL-17, Dan Littman, MD, PhD, New York University
• IL-35 or T Regs, Dario Vignali, PhD, St. Jude Children’s Hospital
• IL-22 & Gut, Atsushi Mizoguchi, MD, PhD, Massachusetts General Hospital
• TSLP, Steven Ziegler, PhD, Benaroya Research Institute
|
